Loading company…
PostEra uses machine learning for medicinal chemistry and preclinical drug discovery.
Founded in 2019 and based in Massachusetts, US, PostEra applies machine learning to preclinical drug discovery and medicinal chemistry. Its work includes COVID oral antiviral candidates through COVID Moonshot and drug discovery programs with biopharma partners. In January 2022, the company raised USD 24 million in Series A financing led by Clermont Group, with Breyer Capital, I2BF, and LifeForce Capital participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in